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EFFECT OF TREATMENT WITH THE CATHEPSIN-K
INHIBITOR, BALICATIB, ON CARTILAGE VOLUME AND
BIOCHEMICAL MARKERS OF BONE AND CARTILAGE
DEGRADATION IN PATIENTS WITH PAINFUL KNEE
OSTEOARTHRITIS
D. Manicourt1, A. Beaulieu2, P. Garnero3, C. Peterfy4,
F. Bouisset5, S. Haemmerle5, L. Mindeholm5
1Université catholique de Louvain, Brussel, Belgium; 2Laval
University, Quebec, PQ, Canada; 3INSERM and Synarc, Lyon,
France; 4Synarc, Inc, San Francisco, CA; 5Novartis Pharma AG,
Basel, Switzerland
Purpose: Cathepsin K is a cysteine protease that has the ca-
pacity to degrade several key matrix components in bone and
cartilage, including type I and II collagens. Balicatib is a novel,
orally bioavailable, speciﬁc cathepsin K inhibitor and potentially
a disease modifying osteoarthritis (OA) drug.
Methods: This randomized, placebo-controlled trial, initially
planned for 12 months, included 152 women and 71 men (mean
age 63) with established knee OA (mean disease duration 10
years) with Kellgren-Lawrence (K-L) grade III at the target knee
and multiple risk factors for disease progression. The contralat-
eral knee was also frequently affected (K-L II 36.8%, K-L III
35.9% and K-L IV 24.7%). The majority of patients had addi-
tionally OA at joints other than the knee (39.9% hand; 61.9%
spine, and 18.8% hip OA). At baseline, median pain on a vi-
sual analogue scale (100mm) was 59 mm (interquartile range
47-73). Patients were randomized to receive either 10 (n=55),
25 (n=55), or 50 mg balicatib (n=58) or a placebo (n=55) daily.
Because of a skin safety signal in a preceding osteoporosis
trial, treatment was terminated early at 6 months, with a 6
month off-treatment follow-up. The primary endpoint was ab-
solute change in most affected medial or lateral compartment
cartilage volume measured by MRI. Bone (serum CTX-I) and car-
tilage markers (urinary CTX-II) of degradation were secondary
endpoints.
Results: There was no statistical signiﬁcant difference of MRI
assessed cartilage volume in the target knee at 6 months (pri-
mary endpoint) between any dose of balicatib and placebo. Six
months after stopping therapy, there was a statistically signiﬁcant
loss of cartilage volume in the two highest doses of balicatib
compared to placebo in the target knee, but not in the contralat-
eral joint. There was a statistical signiﬁcant decrease of CTX-I
and CTX-II in all balicatib groups compared to placebo at 1 and
3 months. After 6 months, the 25 mg dose group showed the
largest decrease compared to placebo with -44.9% (p=0.002)
for CTX-I and -50.3% (p<0.0001) for CTX-II. After treatment
discontinuation a signiﬁcant increase of CTX-I and CTX-II was
seen. At six months after stopping balicatib, CTX-I (+14%, NS)
and CTX-II (+55.6%, p=0.025) remained elevated compared to
placebo for the 50 mg dose group. The rebound increase of
Abstract 230 – Table 1. Radial pQCT vs radiographic knee OA
Radial pQCT K&L P value
(0-1) (2-4) univariate multivariate
mean±sd mean±sd
Radius total area 4% 489.2 (1.1) 487.1 (1.1) 0.76 1.0
Radius total density 4% 326.8 (1.2) 337.6 (1.2) 0.10 0.61
Radius trabecular density 4% 205.9 (1.3) 219.3 (1.3) 0.01 0.09
Radius polar strength strain index 66% 389.6 (1.2) 388.9 (1.3) 0.94 0.89
Radius total area 66% 179.9 (1.2) 181.9 (1.2) 0.51 0.60
Radius cortical density 66% 1113.3 (1.0) 1111.5 (1.0) 0.71 0.70
Radius cortical area 66% 98.6 (1.2) 99.0 (1.2) 0.81 0.67
Radius fracture load x 776.5 (1.2) 777.1 (1.3) 0.98 0.97
Radius fracture load y 847.6 (1.2) 862.8 (1.2) 0.43 0.95
CTX-I after stopping balicatib was more pronounced in women
than in men.
Aside from a higher incidence of skin adverse events (mainly
pruritus; 34.5% in the 25 mg dose group, 23.6% in the placebo
group) and of upper respiratory infections, balicatib was generally
safe and well tolerated at all doses up to 25 mg per day.
The sclerodema/morphea-like skin thickening OP study after 9
months, was not seen under treatment in the OA study, however
1 patient developed a possible case beginning 59 days after stop
of 4 months therapy.
Conclusions: Treatment with balicatib induced a signiﬁcant re-
duction of bone resorption (CTX-I) and type II collagen degra-
dation (CTX-II), but no signiﬁcant effect on cartilage volume as
assessed by MRI could be observed. The increase in bone
and cartilage turnover markers after stopping treatment with the
highest doses of balicatib is investigated further by a continued
follow up of patients. The post-treatment loss of cartilage volume
found with MRI in the target knee could not be conﬁrmed in the
non-target knee. Pruritus and upper respiratory tract infections
were seen more frequently with balicatib than with placebo.
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IS RADIOGRAPHIC KNEE OSTEOARTHRITIS
ASSOCIATED WITH SIZE AND DENSITY AT THE RADIUS
AS MEASURED BY PERIPHERAL QUANTITATIVE CT?
M. Abdin-Mohamed, K. Jameson, E.M. Dennison, A. Aihie
Sayer, C. Cooper, N.K. Arden
MRC Epidemiology Resource Centre, Southampton, United
Kingdom
Purpose: Osteoarthritis (OA) has previously been shown to be
associated with an increase in areal bone mineral density as
assessed by DXA scanning. Despite the proven increase in BMD
there is no associated reduction in fracture risk. The aim of
this study is to determine whether knee OA is associated with
changes in volumetric BMD, bone size and strength measured
by pQCT at a site distant from the knee such as the radius.
Methods: We studied men and women from the MRC Hertford-
shire Cohort Study, a population who have been phenotyped for
osteoarthritis and osteoporosis. They have been shown to be
representative of England and Wales. Subjects completed com-
prehensive health questionnaires and underwent detailed anthro-
pometric measurements in addition to weight bearing extended
knee x-rays which were graded for radiographic osteoarthritis
using the modiﬁed Kellgren and Lawrence criteria and for osteo-
phytes. A grade of ≥ 2 was classiﬁed as presence for both OA
and osteophytes. Bone density was also performed at the non-
dominant radius using pQCT (Stratec 4500 instrument); mea-
surements included: radial total density, total area and trabecular
density at the 4% site, radial cortical density, cortical area, total
area and polar strength strain index at the 66% site and radial
fracture load x and y. The associations between OA and pQCT
parameters were analysed using analyses of variance (ANOVA).
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Results: We studied 303 men and 307 women with a mean
age of 65.6 years and BMI of 26.5 kg/m2. The prevalence of
radiographic tibio- femoral OA (modiﬁed K&L ≥2) was 16.7%
and of osteophytes (≥ grade 2) was 14.4%. The mean radius
total density at 4% and mean radial trabecular density at 4%
were 328.6 (1.2) gm/cm3 and 208.1 (1.3) gm/cm3 respectively.
Univariate analyses demonstrated an increase in trabecular BMD
at the 4% site with the presence of knee OA (see table) and for
trabecular and total BMD with osteophyte grade.There were
no signiﬁcant differences for any of the other bone variables.
However all of these associations disappeared on adjusting for
gender and BMI.
Conclusions: Radiographic knee OA was not associated with
volumetric BMD, bone size or strength at the radius in this cohort
after adjusting for gender and BMI. This suggests OA of the
knee has no association with BMD at sites distant from the site
of the affected joint and that previous increases in areal BMD
may have been due to the limitations of DXA. This may explain
why patients with OA do not have a reduced risk of fracture.
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SYMMETRY OF RADIOGRAPHIC KNEE
OSTEOARTHRITIS PROGRESSION IN SIBLING PAIRS
WITH HAND OSTEOARTHRITIS
V. Byers-Kraus1, G. Cicconetti2, J.M. Jordan3, J. Renner3,
M. Doherty4, A.G. Wilson5, R. Moskowitz6, M. Hochberg7,
R. Loeser8, U. Atif2
1Duke University, Durham, NC; 2GlaxoSmithKline, Research
Triangle Park, NC; 3University of North Carolina, Chapel Hill,
NC; 4University of Nottingham, Nottingham, United Kingdom;
5University of Shefﬁeld, Shefﬁeld, United Kingdom; 6Case
Western Reserve University, Cleveland, OH; 7University of
Maryland, Baltimore, MD; 8Wake Forest University Health
Sciences, Winston-Salem, NC
Purpose: Knee osteoarthritis (OA) progression leads to severe
disability and the need for surgical intervention. We hypothesized
that progression of OA in one knee would increase the likelihood
of progression in the contralateral knee. The objective of this
study was to evaluate the association of knee OA progression
across knees in individuals selected for hand OA and enrolled in
the Genetics of Generalized Osteoarthritis (GoGo) study.
Methods: A total of 1333 participants (79% female, mean age
69 years) of the GoGo cohort were evaluated at baseline and 1
- 7.5 (mean 3.8) years later. Inclusion required 3 joint and bilat-
eral bony enlargement in the hands of at least 2 siblings willing
to participate. Fixed ﬂexion posterior anterior knee radiographs
were scored for change in the following radiographic param-
eters: minimal joint space (MJS), Kellgren Lawrence (KL)
grade, osteophyte (OST), and joint space narrowing (JSN),
of the medial and lateral compartments. Regression analyses
were used to assess the association of radiographic parameters
across knees.
Results: At baseline, only 25% of participants had KL grade O
knees bilaterally and the KL grades of the knees were typically
Abstract 231 – Table 1. Symmetry of knee OA progression
MJS Right Knee - MJS Right Knee - MJS Left Knee - MJS Left Knee -
Medial Compartment Lateral Compartment Medial Compartment Lateral Compartment
Ipsilateral-medial -0.226 (812)* -0.2137 (829)*
Ipsilateral-lateral -0.226 (812)* -0.2137 (829)*
Contralateral-medial 0.4609 (1117)* -0.0822 (774) 0.4609 (1117)* -0.0257 (788)
Contralateral-lateral -0.0257 (788) 0.4462 (721)* -0.0822 (774) 0.4462 (721)*
Sum KLG -0.2388 (1174)* -0.00007(819) -0.1596 (1129)* -0.0054 (796)
Sum Osteophytes -0.0768 (1172) 0.0241 (815) -0.1483 (1179)* -0.0585 (834)
Sum JSN -0.3787 (1164)* -0.0488 (812) -0.4009 (1168)* -0.1094 (832)
Values are Pearson R coefﬁcients (N individuals with data available for analysis of a particular set of variables) *p<0.0001.
the same or within 1 grade of each other in the majority of par-
ticipants (89%). With regard to knee OA progression, signiﬁcant
correlations were observed in a symmetic pattern across com-
partments of the knee (Table 1). Namely, medial compartment
progression in one knee was strongly associated with medial
compartment progression in the contralateral knee. Likewise,
lateral compartment progression in one knee was strongly asso-
ciated with lateral compartment progression in the contralateral
knee.
Conclusions: Although we hypothesized that knee OA progres-
sion in one knee would increase the likelihood of progression
in the contralateral knee, we were surprised to observe remark-
able compartmental symmetry of knee OA progression. This
was particularly intriguing given the method of recruitment that
required hand but not knee OA. These data show that knee
OA is both frequent, and progression compartmentally sym-
metric in siblings from families with hand OA, favouring strong
genetic/constitutional risk for progression.
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HIGH HAND JOINT MOBILITY IS ASSOCIATED WITH
RADIOLOGICAL CMC1 OSTEOARTHRITIS: THE AGES
REYKJAVIK STUDY
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G. Eiriksdottir4, S. Sigurdsson4, T. Aspelund4, T.B. Harris5,
V. Gudnason6
1Landspitalinn University Hospital, Reykjavik, Iceland;
2University of North Carolina, Chapel Hill, NC; 3Roentgen
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Association, Reykjavik, Iceland; 5National Institute on Aging,
Bethesda, MD; 6University of Iceland, Reykjavik, Iceland
Purpose: Previous studies have indicated that joint hypermo-
bility may affect the development of clinical and radiological
hand osteoarthritis, but this question has not been addressed
in epidemiological studies. Our objective was to investigate this
relation in a population based study.
Methods: The study group were 384 randomly selected elderly
individuals taking part in the AGES Reykjavik study (161 males,
median age 76, range 69-90, and 223 females median age 75,
range 69-92). They had a clinical examination for hand joint
mobility and standard hand radiographs. The criterion used for
joint mobility was the maximal degree of passive dorsiﬂexion of
digits 2 and 5 on both sides (HYP°). The radiographs were read
according to the Kellgren-Lawrence (K-L) scoring system.
Results: HYP° was more prevalent in females and on the left
side in both genders. It had a nonsigniﬁcant negative correlation
with age. On bivariate analysis of the relationship between HYP°
and radiological scores in individual joints, there was a con-
sistent tendency for both genders to have a positive association
between the degree of mobility measured by HYP° and radiologi-
cal CMC1 scores. Thus, those with HYP1 >70° had an odds ratio
of 3,05(1,69-5,5, p3 in a CMC1 joint. Multiple logistic regression
analysis including age and gender also showed an association
between HYP° and CMC1 radiological scores (p<0,001). There
